The CEO as well as many major holders sold a significant amount of shares. I'm guessing they can see it's overvalued and want to get out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025